Avalon to Release Second Quarter 2006 Financial Results on August 8, 2006
July 31 2006 - 11:00AM
PR Newswire (US)
GERMANTOWN, Md., July 31 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and NYSE Arca: AVRX) today announced
that it is scheduled to release financial results for the second
quarter and year to date of 2006, on Tuesday, August 8, 2006 after
the close of the U.S. financial markets. The Company will host a
conference call on Wednesday, August 9, 2006 at 8:00 a.m. Eastern
Time to provide a company update and discuss the financial results
for the quarter. Interested investors, analysts, members of the
media and the general public can listen to the call live over the
Internet from the investor section of the Company's website or by
dialing the numbers listed below. Conference Call Details:
------------------------ Dial-In: 866.314.4865 (U.S.) 617.213.8050
(International) Passcode: 45355581 Webcast: Please go to
http://www.avalonrx.com/, Investors, within 15 minutes prior to the
call and select the webcast link. The conference call replay will
be available through September 30, 2006 on Avalon's website
(http://www.avalonrx.com/). About Avalon Pharmaceuticals Avalon
Pharmaceuticals is a biopharmaceutical company focused on the
discovery and development of small molecule therapeutics. Avalon
seeks to discover and develop novel therapeutics through the use of
a comprehensive, innovative and proprietary suite of technologies
based upon large-scale gene expression analysis which it calls
AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is
headquartered in Germantown, Maryland. DATASOURCE: Avalon
Pharmaceuticals, Inc. CONTACT: Gary Lessing, Executive Vice
President and CFO of Avalon Pharmaceuticals, Tel: +1-301-556-9900,
Fax: +1-301-556-9910, or Email: Web site: http://www.avalonrx.com/
Copyright